泰德医药(03880)

19.740-0.140-0.70%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
泰德医药
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.medtideinc.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
泰德医药（浙江）股份有限公司是一家主要从事多肽的合约研究、开发和生产的中国公司。该公司主要提供合约研究机构（CRO）服务，即多肽新化学实体（NCE）发现合成、合约开发及生产机构（CDMO）服务即多肽化学、制造及控制（CMC）开发以及商业化生产。该公司的服务主要专注于向客户提供活性药物成分（APIs），而非药品。该公司也为客户提供多肽类药物开发、生产、CMC申报支持服务。该公司主要在国内市场和海外市场开展业务。
- 05-27
  股份购回
  2025年股东周年大会通函
  2025年股东周年大会通函
- 04-23
  年度报告
  2025年度报告
  2025年度报告
- 03-30
  年度报告
  截至2025年12月31日止年度之年度业绩公告
  截至2025年12月31日止年度之年度业绩公告
- 02-26
  业绩预告
  正面盈利预告
  正面盈利预告
- 2025-09-25
  半年度报告
  2025中期报告
  2025中期报告
- 2025-08-29
  半年度报告
  截至2025年6月30日止六个月之中期业绩公告
  截至2025年6月30日止六个月之中期业绩公告
- 2025-06-20
  股份发售
  全球发售
  全球发售

分时
5日
日
周
月

数据加载中...

最高

19.750

今开

19.140

量比

0.75

最低

19.000

昨收

19.880

换手率

0.07%

热议股票

{"pagemeta":{"title":"泰德医药(03880)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰德医药(03880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰德医药,03880,泰德医药股票,泰德医药股票老虎,泰德医药股票老虎国际,泰德医药行情,泰德医药股票行情,泰德医药股价,泰德医药股市,泰德医药股票价格,泰德医药股票交易,泰德医药股票购买,泰德医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰德医药(03880)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰德医药(03880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"03880","data":{"stockData":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"泰德医药","latestPrice":19.74,"timestamp":1780646017826,"preClose":19.88,"halted":0,"volume":102500,"delay":0,"changeRate":-0.007042253521126789,"floatShares":141800000,"shares":141800000,"eps":1.8832249598495823,"marketStatus":"休市中","change":-0.14,"latestTime":"06-05 15:53:37","open":19.14,"high":19.75,"low":19,"amount":1976318,"amplitude":0.037726,"askPrice":19.74,"askSize":600,"bidPrice":19.38,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":1.960633593168553,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780882200000},"marketStatusCode":7,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":19.88,"openAndCloseTimeList":[[1780623000000,1780632000000],[1780635600000,1780646400000]],"volumeRatio":0.7509157502556051,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"21316410","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3b1rRhJHW1","pdf_url":"https://static.tigerbbs.com/e8b8a95b69fd43c0bd11434d0dc4072c","pub_time":1779892860000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025年股东周年大会通函","symbol":"03880","title":"2025年股东周年大会通函","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0527/2026052701911_c.pdf","us_notice_code":"通函 - [一般性授权 / 修订宪章文件 / 在股东批准的情况下重选或委任董事 / 回购股份的说明函件 / 其他]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2026-05-27 22:41","pubTimestamp":1779892860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"21083628","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7xihCzQMU1","pdf_url":"https://static.tigerbbs.com/7bfff864dd1b4ce4ad3e7b69998da160","pub_time":1776954540000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025年度报告","symbol":"03880","title":"2025年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042303035_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-04-23 22:29","pubTimestamp":1776954540,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20923353","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFoozNMPx5V","pdf_url":"https://static.tigerbbs.com/7a0e49406c844cc19f6ef05290c172e0","pub_time":1774874100000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年12月31日止年度之年度业绩公告","symbol":"03880","title":"截至2025年12月31日止年度之年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033001899_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-03-30 20:35","pubTimestamp":1774874100,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20766575","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8HF9XSQi67","pdf_url":"https://static.tigerbbs.com/ccd217c3cae0408a82223d2367217d44","pub_time":1772064000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"正面盈利预告","symbol":"03880","title":"正面盈利预告","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0226/2026022600039_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2026-02-26 08:00","pubTimestamp":1772064000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20203590","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3JZ7VDsurq","pdf_url":"https://static.tigerbbs.com/5d83a6f41f3f476d9cab2d30091053e8","pub_time":1758789000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025中期报告","symbol":"03880","title":"2025中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0925/2025092500382_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-25 16:30","pubTimestamp":1758789000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20101649","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFEBh1XFMNU","pdf_url":"https://static.tigerbbs.com/4bc5a099078240f2a9bc375aae9f4881","pub_time":1756458420000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月之中期业绩公告","symbol":"03880","title":"截至2025年6月30日止六个月之中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082901290_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-29 17:07","pubTimestamp":1756458420,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19789503","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3UxMyr2aCR","pdf_url":"https://static.tigerbbs.com/28fd3ef8429847e7a44d031bcb3edec6","pub_time":1750371780000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球发售","symbol":"03880","title":"全球发售","titleType":"股份发售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0620/2025062000022_c.pdf","us_notice_code":"上市文件 - [发售以供认购]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份发售","pubTime":"2025-06-20 06:23","pubTimestamp":1750371780,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.medtideinc.com","stockEarnings":[{"period":"1week","weight":-0.092},{"period":"1month","weight":-0.0995},{"period":"3month","weight":-0.1265},{"period":"6month","weight":-0.3},{"period":"1year","weight":-0.3549},{"period":"ytd","weight":-0.3524}],"compareEarnings":[{"period":"1week","weight":-0.0088},{"period":"1month","weight":-0.0478},{"period":"3month","weight":-0.0309},{"period":"6month","weight":-0.0431},{"period":"1year","weight":0.0441},{"period":"ytd","weight":-0.0261}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"泰德医药（浙江）股份有限公司是一家主要从事多肽的合约研究、开发和生产的中国公司。该公司主要提供合约研究机构（CRO）服务，即多肽新化学实体（NCE）发现合成、合约开发及生产机构（CDMO）服务即多肽化学、制造及控制（CMC）开发以及商业化生产。该公司的服务主要专注于向客户提供活性药物成分（APIs），而非药品。该公司也为客户提供多肽类药物开发、生产、CMC申报支持服务。该公司主要在国内市场和海外市场开展业务。","exchange":"SEHK","name":"泰德医药","nameEN":"MEDTIDE"},"aProfile":null}}}